The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and ...

The company presented data in June finding that 200-unit reservoirs have enough capacity for only 38% of adults for 72-hour wear, while 300-unit reservoirs would have enough capacity for 64% of adults ...

Among other things, NCPA is urging CMS to require Part D plans/PBMs to notify pharmacies or their contracting entities about the pharmacies’ network status for the upcoming plan year ...

Diabetes affects your body’s ability to produce or use insulin, a hormone that allows your body to turn glucose (sugar) into energy. Below are the symptoms that may occur in your body when ...

Eli Lilly (NYSE:LLY) on Thursday announced that its QWINT-1 and QWINT-3 Phase 3 clinical trials for once-weekly insulin efsitora alfa reached the primary endpoints against daily basal insulins ...

In the phase 3 study, QWINT-1, efsitora was administered via four fixed doses once weekly in a single-use autoinjector in people with type 2 diabetes using basal insulin for the first time In a ...

(RTTNews) - Eli Lilly and Company (LLY) Thursday announced positive topline results from the QWINT-1 and QWINT-3 phase 3 studies evaluating once weekly basal insulin efsitora alfa in adults with ...